ADVERTISEMENT

Q1 Results Updates: Bosch Profit Up Multifold; Aurobindo Pharma Profit Falls 10%, Misses Estimates

Aurobindo Pharma, Kansai Nerolac, report a fall in profit, while DLF, Escorts Kubota see a rise in bottom line.

<div class="paragraphs"><p>Marico, Aurobindo Pharma, Kansai Nerolac, DLF, Escorts Kubota are among the top names that will announce their earnings for the first quarter on Monday (Image source: NDTV Profit)</p></div>
Marico, Aurobindo Pharma, Kansai Nerolac, DLF, Escorts Kubota are among the top names that will announce their earnings for the first quarter on Monday (Image source: NDTV Profit)
ADVERTISEMENT
Marico, Aurobindo Pharma, Kansai Nerolac, DLF, Escorts Kubota are among the top names that announced their earnings for the first quarter on Monday.
LIVE FEED
Latest First
  • Oldest First

Q1 Results Live: GPT Infraprojects Profit Grows

GPT Infraprojects Q1 Highlights (Consolidated, YoY)

  • Revenue up 29.3% to Rs 313 crore versus Rs 242 crore

  • Net Profit up 40% to Rs 23.5 crore versus Rs 16.8 crore

  • Ebitda up 15.3% to Rs 37 crore versus Rs 32.1 crore

  • Margin at 11.8% versus 13.3%


Q1 Results Live: Kitex Garments Profit Tumbles

Kitex Garments Q1 Highlights (Consolidated, YoY)

  • Revenue up 3.3% to Rs 196.69 crore versus Rs 190.43 crore

  • Net Profit down 24% to Rs 20.76 crore versus Rs 27.31 crore

  • Ebitda down 15% to Rs 34.18 crore versus Rs 40.38 crore

  • Margin at 17.4% versus 21.2%


Q1 Results Live: Oswal Pumps Profit Grows

Oswal Pumps Q1 Highlights (Consolidated, YoY)

  • Revenue up 36.8% to Rs 513.90 crore versus Rs 375.60 crore

  • Net Profit up 34% to Rs 94.60 crore versus Rs 70.50 crore

  • Ebitda up 39% to Rs 140.60 crore versus Rs 101.40 crore

  • Margin at 27.4% versus 27.0%


Q1 Results Live: Bosch Profit Up Multifold

Bosch Q1 Highlights (Consolidated, YoY)

  • Revenue up 10.9% to Rs 4,788.00 crore versus Rs 4,316.80 crore

  • Net Profit at Rs 1,115.00 crore versus Rs 465.00 crore

  • Ebitda up 23% to Rs 638.70 crore versus Rs 520.00 crore

  • Margin at 13.3% versus 12.0%

  • The June quarter includes exceptional gain of Rs 556 crore.


Q1 Results Live: Aurobindo Pharma Profit Falls

Aurobindo Pharma Q1 Highlights (Consolidated, YoY)

  • Revenue up 4.0% to Rs 7,868.00 crore versus Rs 7,567.00 crore (Estimate: Rs 8,196.60 crore).

  • Net Profit down 10% to Rs 824.70 crore versus Rs 919.00 crore (Estimate: Rs 940.00 crore).

  • Ebitda down 1% to Rs 1,602.90 crore versus Rs 1,619.40 crore (Estimate: Rs 1,726.60 crore).

  • Margin at 20.4% versus 21.4% (Estimate: 21.06%).




























OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit